Market Tracker

08/28 6:01pm ET

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

6.42
Delayed Data
As of Aug 28
 +0.22 / +3.55%
Today’s Change
5.25
Today|||52-Week Range
18.48
-54.63%
Year-to-Date

Today’s Trading

Previous close6.20
Today’s open6.20
Day’s range6.20 - 6.64
Volume1,062,670
Average volume (3 months)1,594,179
Market cap$675.2M
Dividend yield--
Data as of 3:59pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)-112.07%
Earnings growth (this year)+19.38%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+54.64%
P/E ratioNM
Price/Sales118.95
Price/Book8.10

Competitors

 Today’s
change
Today’s
% change
AMRIAlbany Molecular Res...+0.64+3.21%
SGMOSangamo BioSciences ...+0.10+1.29%
FLXNFlexion Therapeutics...+0.58+2.35%
AMRNAmarin Corporation P...+0.14+6.70%
Data as of 3:59pm ET, 08/28/2015

Financials

Next reporting dateNovember 5, 2015
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$10.8M
Annual profit (last year)-$111.5M
Net profit margin-1,030.19%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Gregory P. Madison
Chief Financial Officer
Scott A. Holmes
Corporate headquarters
New York, New York

Forecasts